ProVerum Medical
PrivateLast Round
Series B
Aug 25, 2025
Total Funding Raised
$124.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ProVerum Medical operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Series B round in August 2025.
ProVerum Medical is a medical device company that develops minimally invasive technologies for the treatment of benign prostatic hyperplasia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProVerum Medical Comparables
Compare ProVerum Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zenflow | 93% | |
| Butterfly Medical | 92% | |
| Rivermark Medical | 87% |
For institutional investors. Book with your work email.
ProVerum Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 25, 2025 | ||||
| Grant | Mar 8, 2025 | ||||
| Series A | Jan 11, 2022 | ||||
| Grant | Mar 12, 2020 | ||||
| Seed | Jul 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProVerum Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series A, Series B |
| Lightstone Ventures | Series B, Series A |
| OrbiMed | Series B |
| Gilde Healthcare | Series B, Series A |
| Disruptive Technologies Innovation Fund | Grant |
| Irrus Investments | Seed |
| National Treasury Management Agency | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Open roles increased to 22, 2.4x the trailing average.
- Sep 28, 2026
Open roles increased to 17, 29% of headcount.
For institutional investors. Book with your work email.
ProVerum Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProVerum Medical's valuation, stock price, and market status.
Is ProVerum Medical a public or private company?
ProVerum Medical is a private company.
What is the current stock price of ProVerum Medical?
ProVerum Medical is a private company, so its shares have no public market price. Caplight tracks ProVerum Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProVerum Medical worth (valuation)?
Valuation information for ProVerum Medical is not publicly available.
Can I buy ProVerum Medical stock?
ProVerum Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProVerum Medical's last funding round?
ProVerum Medical's most recent funding round was Series B on August 25, 2025.
Who are the main investors in ProVerum Medical?
Key investors in ProVerum Medical include Lightstone Ventures, Gilde Healthcare, MVM Life Science Partners LLP.
Will ProVerum Medical IPO soon?
No public IPO plans have been announced for ProVerum Medical.
How can I track ProVerum Medical secondary market activity?
Caplight tracks bids, offers, and trades in ProVerum Medical's shares on secondary markets.